 Atea Pharmaceuticals, Inc. NASDAQ:AVIR Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President of Investor Relations Corporate Communications Jean-Pierre Sommadossi - Chief Executive Officer Founder Janet Hammond - Chief Development Officer Andrea Corcoran - Chief Financial Officer Executive President of Legal John Vavricka - Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair Nik Gasic - SVB Securities Operator Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. 